Retinal Vasculopathy With Cerebral Leukoencephalopathy And Systemic Manifestations

Description

Retinal vasculopathy and cerebral leukodystrophy (RVCL) is an inherited group of small vessel diseases comprised of cerebroretinal vasculopathy (CRV), hereditary vascular retinopathy (HRV) and hereditary endotheliopathy with retinopathy, nephropathy and stroke (HERNS; see these terms); all exhibiting progressive visual impairment as well as variable cerebral dysfunction.

Clinical Features

Top most frequent phenotypes and symptoms related to Retinal Vasculopathy With Cerebral Leukoencephalopathy And Systemic Manifestations

  • Seizures
  • Ataxia
  • Neoplasm
  • Pain
  • Visual impairment
  • Hyperreflexia
  • Dysarthria
  • Edema
  • Behavioral abnormality
  • Headache

And another 43 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Retinal Vasculopathy With Cerebral Leukoencephalopathy And Systemic Manifestations Is also known as retinopathy, vascular, with cerebral and renal involvement and raynaud and migraine phenomena, cerebroretinal vasculopathy, hereditary, crv, retinal vasculopathy and cerebral leukoencephalopathy, rvcl, rvcl-s.

Researches and researchers

Doctors, researchs, and experts related to Retinal Vasculopathy With Cerebral Leukoencephalopathy And Systemic Manifestations extracted from public data.

Retinal Vasculopathy With Cerebral Leukoencephalopathy And Systemic Manifestations Experts map



Current Researchs and researchers

  • PARIS — Pr Yanick CROW

    Coordinator of expert centre - Clinical expert - Investigator of research project - Sponsor of orphan designation - Coordinator of research network

    • Institution/s:
      — Manchester Regional Genetics Service, Genetic Medicine, 6th Floor, St Mary's Hospital
      — Central Manchester University Hospitals NHS Foundation Trust, St Mary's Hospital
      — Institut Imagine - INSERM U1163, IMAGINE - Institut des Maladies Génétiques
    • Research area/topic::

      NIMBL: Nuclease Immune Mediated Brain and Lupus-like conditions (NIMBL): natural history, pathophysiology, diagnostic and therapeutic modalities with application to other disorders of autoimmunity (TERMINATED)


  • TÜBINGEN — Pr Bernd WISSINGER

    Investigator of research project - Manager of registry - Manager of biobank/collection - Coordinator of research network - Director of laboratory

    • Institution/s:
      — Forschungsinstitut für Augenheilkunde, Department für Augenheilkunde Tübingen
    • Research area/topic::

      RETNET: European Retinal Research Training Network


  • MANCHESTER — Pr Yanick CROW

    Coordinator of expert centre - Clinical expert - Investigator of research project - Sponsor of orphan designation - Coordinator of research network

    • Institution/s:
      — Manchester Regional Genetics Service, Genetic Medicine, 6th Floor, St Mary's Hospital
      — Central Manchester University Hospitals NHS Foundation Trust, St Mary's Hospital
      — Institut Imagine - INSERM U1163, IMAGINE - Institut des Maladies Génétiques
    • Research area/topic::

      NIMBL: Nuclease Immune Mediated Brain and Lupus-like conditions (NIMBL): natural history, pathophysiology, diagnostic and therapeutic modalities with application to other disorders of autoimmunity (TERMINATED)


Retinal Vasculopathy With Cerebral Leukoencephalopathy And Systemic Manifestations Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Epilepsy Advanced Sequencing and CNV Evaluation.

By Athena Diagnostics Inc (United States).

SCN1A, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SHH, ST3GAL3, ST3GAL5, STIL, SIX3, SLC2A1, SLC35A2, SLC6A1, SLC6A8, SLC9A6, SMC1A, KDM5C, SMS , (...)

View the complete list with 214 more genes
Specificity
1 %
Genes
100 %
Epilepsy Advanced Sequencing and CNV Evaluation-Epileptic Encephalopathy.

By Athena Diagnostics Inc (United States).

SCN1A, SCN1B, SCN2A, SCN8A, SCN9A, ST3GAL5, SLC2A1, SLC35A2, SLC9A6, SIK1, SPTAN1, CDKL5, STXBP1, SYNGAP1, TCF4, TREX1, UBE3A, WWOX, CNTNAP2, CACNA2D1 , (...)

View the complete list with 47 more genes
Specificity
2 %
Genes
100 %
Hereditary Spastic Paraplegia Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).

RTN2, SACS, SLC16A2, SLC2A1, KDM5C, SPG11, ATL1, SPAST, SPG7, TFG, ACOX1, TREX1, UCHL1, VAMP1, ERLIN2, CAPN1, BSCL2, SAMHD1, PNPLA6, ERLIN1 , (...)

View the complete list with 59 more genes
Specificity
2 %
Genes
100 %
Aicardi-Goutieres Syndrome 1 - TREX1 Del/Dup Analysis.

By Children's Hospital Colorado Molecular Genetics Laboratory Children's Hospital Colorado (United States).

TREX1
Specificity
100 %
Genes
100 %
Aicardi-Goutieres Syndrome 1 - TREX1 Sequencing.

By Children's Hospital Colorado Molecular Genetics Laboratory Children's Hospital Colorado (United States).

TREX1
Specificity
100 %
Genes
100 %
Dystonia.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).

SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SPR, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, FBXO7, CACNA1A, NPC2, PINK1, PANK2, SAMHD1, APTX , (...)

View the complete list with 57 more genes
Specificity
2 %
Genes
100 %
Movement Disorders Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).

SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SNCA, SPR, SQSTM1, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, VPS35, FBXO7, CACNA1A, NPC2, PINK1 , (...)

View the complete list with 72 more genes
Specificity
2 %
Genes
100 %
Dystonia Exome Panel.

By Genetic Services Laboratory University of Chicago (United States).

BCS1L, SCN8A, SCP2, SDHA, SGCE, SLC16A2, SLC20A2, SLC2A1, SLC6A3, SLC6A8, SPR, SQSTM1, STXBP1, SUCLA2, SUOX, SURF1, SYNJ1, TAF1, TBCD, TH , (...)

View the complete list with 150 more genes
Specificity
1 %
Genes
100 %

You can get up to 82 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

ORPHANET MESH OMIM Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20